Literature DB >> 19343380

The antimalarial activity of Ru-chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water/n-octanol interfaces.

Alberto Martínez1, Chandima S K Rajapakse, Dalanda Jalloh, Cula Dautriche, Roberto A Sánchez-Delgado.   

Abstract

We have measured water/n-octanol partition coefficients, pK(a) values, heme binding constants, and heme aggregation inhibition activity of a series of ruthenium-pi-arene-chloroquine (CQ) complexes recently reported to be active against CQ-resistant strains of Plasmodium falciparum. Measurements of heme aggregation inhibition activity of the metal complexes near water/n-octanol interfaces qualitatively predict their superior antiplasmodial action against resistant parasites, in relation to CQ; we conclude that this modified method may be a better predictor of antimalarial potency than standard tests in aqueous acidic buffer. Some interesting tendencies emerge from our data, indicating that the antiplasmodial activity is related to a balance of effects associated with the lipophilicity, basicity, and structural details of the compounds studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343380      PMCID: PMC3378400          DOI: 10.1007/s00775-009-0498-4

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  22 in total

1.  Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains.

Authors:  Cecilia P Sanchez; Jeremy E McLean; Wilfred Stein; Michael Lanzer
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

2.  Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6.

Authors:  M Navarro; H Pérez; R A Sánchez-Delgado
Journal:  J Med Chem       Date:  1997-06-06       Impact factor: 7.446

3.  Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.

Authors:  C Biot; G Glorian; L A Maciejewski; J S Brocard
Journal:  J Med Chem       Date:  1997-11-07       Impact factor: 7.446

4.  Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes.

Authors:  R A Sánchez-Delgado; M Navarro; H Pérez; J A Urbina
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

5.  Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Jeremy E McLean; Petra Rohrbach; David A Fidock; Wilfred D Stein; Michael Lanzer
Journal:  Biochemistry       Date:  2005-07-26       Impact factor: 3.162

6.  Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX.

Authors:  T J Egan; W W Mavuso; D C Ross; H M Marques
Journal:  J Inorg Biochem       Date:  1997-11-01       Impact factor: 4.155

7.  Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes.

Authors:  Maribel Navarro; Flor Vásquez; Roberto A Sánchez-Delgado; Hilda Pérez; Véronique Sinou; Joseph Schrével
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

8.  Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.

Authors:  Chandima S K Rajapakse; Alberto Martínez; Becky Naoulou; Andrzej A Jarzecki; Liliana Suárez; Christiane Deregnaucourt; Véronique Sinou; Joseph Schrével; Elgilda Musi; Grazia Ambrosini; Gary K Schwartz; Roberto A Sánchez-Delgado
Journal:  Inorg Chem       Date:  2009-02-02       Impact factor: 5.165

9.  Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.

Authors:  David C Warhurst
Journal:  Malar J       Date:  2003-09-19       Impact factor: 2.979

10.  The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids.

Authors:  David C Warhurst; John C Craig; Ipemida S Adagu; David J Meyer; Sylvia Y Lee
Journal:  Malar J       Date:  2003-09-01       Impact factor: 2.979

View more
  12 in total

1.  Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.

Authors:  Maribel Navarro; William Castro; Angel R Higuera-Padilla; Anibal Sierraalta; María Jesús Abad; Peter Taylor; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-09-22       Impact factor: 4.155

2.  An epigenetic antimalarial resistance mechanism involving parasite genes linked to nutrient uptake.

Authors:  Paresh Sharma; Kurt Wollenberg; Morgan Sellers; Kayvan Zainabadi; Kevin Galinsky; Eli Moss; Wang Nguitragool; Daniel Neafsey; Sanjay A Desai
Journal:  J Biol Chem       Date:  2013-05-28       Impact factor: 5.157

3.  Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.

Authors:  Alberto Martínez; Teresia Carreon; Eva Iniguez; Atilio Anzellotti; Antonio Sánchez; Marina Tyan; Aaron Sattler; Linda Herrera; Rosa A Maldonado; Roberto A Sánchez-Delgado
Journal:  J Med Chem       Date:  2012-04-09       Impact factor: 7.446

4.  Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.

Authors:  Lotta Glans; Andreas Ehnbom; Carmen de Kock; Alberto Martínez; Jesús Estrada; Peter J Smith; Matti Haukka; Roberto A Sánchez-Delgado; Ebbe Nordlander
Journal:  Dalton Trans       Date:  2012-01-17       Impact factor: 4.390

5.  The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.

Authors:  Maribel Navarro; William Castro; Alberto Martínez; Roberto A Sánchez Delgado
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

6.  Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin.

Authors:  Alberto Martínez; Javier Suárez; Tiffany Shand; Richard S Magliozzo; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-01       Impact factor: 4.155

7.  Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells.

Authors:  Alberto Martínez; Chandima S K Rajapakse; Roberto A Sánchez-Delgado; Armando Varela-Ramirez; Carolina Lema; Renato J Aguilera
Journal:  J Inorg Biochem       Date:  2010-05-15       Impact factor: 4.155

8.  Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.

Authors:  Maribel Navarro; William Castro; Marilyn Madamet; Rémy Amalvict; Nicolas Benoit; Bruno Pradines
Journal:  Malar J       Date:  2014-12-03       Impact factor: 2.979

9.  Lipophilicity assessment of ruthenium(II)-arene complexes by the means of reversed-phase thin-layer chromatography and DFT calculations.

Authors:  Khalil Salem A M Shweshein; Filip Andrić; Aleksandra Radoičić; Matija Zlatar; Maja Gruden-Pavlović; Zivoslav Tešić; Dušanka Milojković-Opsenica
Journal:  ScientificWorldJournal       Date:  2014-01-22

10.  Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.

Authors:  Nicolli Bellotti de Souza; Anna Caroline Campos Aguiar; Alane Cabral de Oliveira; Siden Top; Pascal Pigeon; Gérard Jaouen; Marilia Oliveira Fonseca Goulart; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11-24       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.